Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence


The international webinar "Surgical Resection for HCC: Insights into the Indications and the Prognosis" has been held successfully

Published on: 21 Dec 2021 Viewed: 225

The international webinar "Surgical Resection for HCC: Insights into the Indications and the Prognosis", chaired by Dr. Allan Tsung, the Associate Editor of Hepatoma Research, and Director of Department of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA, was successfully held on Dec 12, 2021. Eight guest speakers gave their brilliant presentations on their special interests, respectively. They are Dr. Zachary J. Brown, Dr. Timothy M. Pawlik, Dr. Nicole M. Nevarez, Dr. David A. Geller, Dr. Georgios Tsoulfas, Dr. Nuh N. Rahbari, Dr. Joal Beane, and Dr. Emily R. Winslow. They also conducted heated discussions in the webinar.
The webinar earned huge attention and support from many experts. It was a great honor for Hepatoma Research to have all these experts join together and share their research findings on this academic platform.


Zachary J. Brown, Clinical Instructor in surgical oncology, Division of Surgical Oncology, Department of Surgery, the Ohio State University Wexner Medical Center, Columbus, OH, USA.
Topic: Adjuvant treatment of hepatocellular carcinoma after resection

Timothy M. Pawlik, Chair of the Department of Surgery in the Ohio State University College of Medicine, the Urban Meyer III and Shelley Meyer Chair for Cancer Research, Columbus, OH, USA.
Topic: Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

Nicole M. Nevarez, MD, Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Topic: Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises

David A. Geller, Editorial Board member of Hepatoma Research. Richard L. Simmons Professor of Surgery at the University of Pittsburgh School of Medicine, and Director of the UPMC Liver Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Topic: Outcomes of laparoscopic liver resection for hepatocellular carcinoma

Georgios Tsoulfas, MD, PhD, FACS, Professor of Transplantation Surgery, Chief Department of Transplantation Surgery, Aristotle University School of Medicine, Thessaloniki, Greece.
Topic: The role of technology in the surgical management of hepatocellular carcinoma

Nuh N. Rahbari, Vice Chairman and Professor, Department of Surgery, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Topic: Minimally-invasive surgical management of hepatocellular carcinoma

Joal Beane, Surgical oncologist, Department of Surgery, the Ohio State University Wexner Medical Center and James Comprehensive Cancer Center and Solove Research Institute, Columbus, OH, USA.
Topic: Optimal hepatic surgery

Emily R. Winslow, MD, MedStar's Regional Chief of Hepatopancreaticobiliary Surgery, Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC, USA.
Topic: HCC: Insights from the development of LIRADs

We appreciate all professors who gave us amazing presentations, and we hope all attendees enjoyed this webinar.

Hepatoma Research will hold more webinars and we look forward to having more researchers join us in future webinars!

For more webinars, please visit

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties